Scientific

MK5 Microarray Data

Affected Genes - Ontology Breakdown - Gene Enrichment - Proteome Analysis

These are the micro-array results of a differential gene expression microarray experiments and the subsequent analysis steps performed on them. The up/down- regulation ratio was obtained by measuring WT cells against MK5 activated cells. See material and methods for technical information as well as the data usage policy.

Proteome Analysis

Below the proteome analysis is presented. The analysis methods are presented in the paper Propagating Differential Gene Expression in Protein Interaction Networks. If you are interested in the most reliable results choose the

  • value_type as 'ranked' since this provides a very robust analysis method.
  • intercation map as 'high confidence'
  • network_comparison type as 'Divided' since this leads to a natural grouping of similar proteins
  • filtered as 'true' since this will only use the microarray measurements that have a sufficiently large confidence level.

    • Navigation/Query Panel:
    Click on the attribute name to hide/unhide it. The green arrows can be used to shift columns left/right. Exact word match is written as =..., regular expressions can be matched with ~.... To select all values larger or equal than use >.... This would be <... for values smaller or equal than. To select all values within a specific range use [...,...].
    Rank Gene Hugo description Value Type Network Comparison Type Interaction Map Filtered red green network_comparison
    Results: HTML CSV LaTeX Showing element 480 to 529 of 3228 in total 
    Value Type: Ranked
    Network Comparison Type: Divided
    Interaction Map: High confidence
    Filtered: 1
    
\def\wcA{0.14285714285714\textwidth}
\def\wcB{0.14285714285714\textwidth}
\def\wcC{0.14285714285714\textwidth}
\def\wcD{0.14285714285714\textwidth}
\def\wcE{0.14285714285714\textwidth}
\def\wcF{0.14285714285714\textwidth}
\begin{longtable}{|c|c|c|c|c|c|}
\hline
\parbox{\wcA}{\vspace{3pt}\noindent
Rank\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
Hugo\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
description\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
red\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
green\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
network\_comparison\vspace{3pt}}\\
\hline
\hline
\parbox{\wcA}{\vspace{3pt}\noindent
480\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
NETO2\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
neuropilin- and tolloid-like protein 2 precursor. [source:refseq;acc:nm\_018092]\vspace{3pt}}&\multirow{6}{*}{\parbox{\wcD}{\vspace{3pt}\noindent
237.109\vspace{3pt}}}&\multirow{6}{*}{\parbox{\wcE}{\vspace{3pt}\noindent
254.667\vspace{3pt}}}&\multirow{6}{*}{\parbox{\wcF}{\vspace{3pt}\noindent
1.07405\vspace{3pt}}}\\\cline{1-3}
\parbox{\wcA}{\vspace{3pt}\noindent
481\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
NETO1\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
neuropilin- and tolloid-like protein 1 isoform 3 precursor. [source:refseq;acc:nm\_138966]\vspace{3pt}}&&&\\\cline{1-3}
\parbox{\wcA}{\vspace{3pt}\noindent
482\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
HNRNPU\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
heterogenous nuclear ribonucleoprotein u (hnrnp u) (scaffold attachment factor a) (saf-a). [source:swissprot;acc:q00839]\vspace{3pt}}&&&\\\cline{1-3}
\parbox{\wcA}{\vspace{3pt}\noindent
483\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
RUNX2\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
runt-related transcription factor 2 (core-binding factor, alpha 1 subunit) (cbf-alpha 1) (acute myeloid leukemia 3 protein) (oncogene aml-3) (polyomavirus enhancer binding protein 2 alpha a subunit) (pebp2-alpha a) (pea2-alpha a) (sl3-3 enhancer factor 1 alpha a subunit) (sl3/akv core-binding factor alpha a subunit) (osteoblast- specific transcription factor 2) (osf-2). [source:swissprot;acc:q13950]\vspace{3pt}}&&&\\\cline{1-3}
\parbox{\wcA}{\vspace{3pt}\noindent
484\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
HNRPUL1\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
e1b-55kda-associated protein 5 isoform a. [source:refseq;acc:nm\_007040]\vspace{3pt}}&&&\\\cline{1-3}
\parbox{\wcA}{\vspace{3pt}\noindent
485\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
RPL18\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
60s ribosomal protein l18. [source:swissprot;acc:q07020]\vspace{3pt}}&&&\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
486\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
MCTS1\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
mct-1 protein. [source:refseq;acc:nm\_014060]\vspace{3pt}}&\multirow{2}{*}{\parbox{\wcD}{\vspace{3pt}\noindent
226.313\vspace{3pt}}}&\multirow{2}{*}{\parbox{\wcE}{\vspace{3pt}\noindent
243.03\vspace{3pt}}}&\multirow{2}{*}{\parbox{\wcF}{\vspace{3pt}\noindent
1.07387\vspace{3pt}}}\\\cline{1-3}
\parbox{\wcA}{\vspace{3pt}\noindent
487\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
MRPL22\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
mitochondrial ribosomal protein l22. [source:refseq;acc:nm\_014180]\vspace{3pt}}&&&\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
488\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
SART1\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
squamous cell carcinoma antigen recognized by t cells 1; u4/u6.u5 tri-snrnp-associated 110 kda protein; ige autoantigen; sart1(259) protein; sart1(800) protein. [source:refseq;acc:nm\_005146]\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
225.026\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
209.798\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
1.07258\vspace{3pt}}\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
489\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
PPM1B\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
protein phosphatase 2c beta isoform (ec 3.1.3.16) (pp2c-beta). [source:swissprot;acc:o75688]\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
231.276\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
215.627\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
1.07257\vspace{3pt}}\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
490\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
ARHGEF7\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
rho guanine nucleotide exchange factor 7 (pak-interacting exchange factor beta) (beta-pix) (cool-1) (p85). [source:swissprot;acc:q14155]\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
220.183\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
236.015\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
1.0719\vspace{3pt}}\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
491\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
GTPBP4\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
nucleolar gtp-binding protein 1 (chronic renal failure gene protein) (gtp-binding protein ngb). [source:swissprot;acc:q9bze4]\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
251.83\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
234.951\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
1.07184\vspace{3pt}}\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
492\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
PAK2\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
serine/threonine-protein kinase pak 2 (ec 2.7.1.-) (p21-activated kinase 2) (pak-2) (pak65) (gamma-pak) (s6/h4 kinase). [source:swissprot;acc:q13177]\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
220.171\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
235.979\vspace{3pt}}&\multirow{4}{*}{\parbox{\wcF}{\vspace{3pt}\noindent
1.0718\vspace{3pt}}}\\\cline{1-5}
\parbox{\wcA}{\vspace{3pt}\noindent
493\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
COG5\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
conserved oligomeric golgi complex subunit 5 (13s golgi transport complex 90 kda subunit) (gtc-90) (golgi transport complex 1). [source:swissprot;acc:q9up83]\vspace{3pt}}&\multirow{2}{*}{\parbox{\wcD}{\vspace{3pt}\noindent
220.172\vspace{3pt}}}&\multirow{2}{*}{\parbox{\wcE}{\vspace{3pt}\noindent
235.98\vspace{3pt}}}&\\\cline{1-3}
\parbox{\wcA}{\vspace{3pt}\noindent
494\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
PAK1\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
serine/threonine-protein kinase pak 1 (ec 2.7.1.-) (p21-activated kinase 1) (pak-1) (p65-pak) (alpha-pak). [source:swissprot;acc:q13153]\vspace{3pt}}&&&\\\cline{1-5}
\parbox{\wcA}{\vspace{3pt}\noindent
495\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
PAK3\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
serine/threonine-protein kinase pak 3 (ec 2.7.1.-) (p21-activated kinase 3) (pak-3) (beta-pak) (oligophrenin-3). [source:swissprot;acc:o75914]\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
220.171\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
235.979\vspace{3pt}}&\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
496\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
PPAN-P2RY11\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
suppressor of swi4 1 homolog (ssf-1) (peter pan homolog). [source:swissprot;acc:q9nq55]\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
250.938\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
234.134\vspace{3pt}}&\multirow{2}{*}{\parbox{\wcF}{\vspace{3pt}\noindent
1.07177\vspace{3pt}}}\\\cline{1-5}
\parbox{\wcA}{\vspace{3pt}\noindent
497\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
EBNA1BP2\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
probable rrna processing protein ebp2 (ebna1 binding protein 2) (nucleolar protein p40). [source:swissprot;acc:q99848]\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
251.344\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
234.514\vspace{3pt}}&\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
498\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
ARHGEF6\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
rho guanine nucleotide exchange factor 6 (pak-interacting exchange factor alpha) (alpha-pix) (cool-2). [source:swissprot;acc:q15052]\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
220.161\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
235.95\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
1.07172\vspace{3pt}}\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
499\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
TPI1\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
triosephosphate isomerase (ec 5.3.1.1) (tim). [source:swissprot;acc:p00938]\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
231.496\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
248.048\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
1.0715\vspace{3pt}}\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
500\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
ING2\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
inhibitor of growth family, member 1-like; inhibitor of growth 1-like. [source:refseq;acc:nm\_001564]\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
224.662\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
240.673\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
1.07127\vspace{3pt}}\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
501\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
CYC1\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
cytochrome c1, heme protein, mitochondrial precursor (cytochrome c-1). [source:swissprot;acc:p08574]\vspace{3pt}}&\multirow{4}{*}{\parbox{\wcD}{\vspace{3pt}\noindent
238.704\vspace{3pt}}}&\multirow{4}{*}{\parbox{\wcE}{\vspace{3pt}\noindent
255.68\vspace{3pt}}}&\multirow{4}{*}{\parbox{\wcF}{\vspace{3pt}\noindent
1.07112\vspace{3pt}}}\\\cline{1-3}
\parbox{\wcA}{\vspace{3pt}\noindent
502\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
ARHGAP26\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
oligophrenin-1 like protein (gtpase regulator associated with focal adhesion kinase). [source:swissprot;acc:q9una1]\vspace{3pt}}&&&\\\cline{1-3}
\parbox{\wcA}{\vspace{3pt}\noindent
503\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
RGN\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
senescence marker protein-30 (smp-30) (regucalcin) (rc). [source:swissprot;acc:q15493]\vspace{3pt}}&&&\\\cline{1-3}
\parbox{\wcA}{\vspace{3pt}\noindent
504\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
OPHN1\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
oligophrenin 1. [source:swissprot;acc:o60890]\vspace{3pt}}&&&\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
505\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
NOC3L\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
ad24 protein. [source:refseq;acc:nm\_022451]\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
251.334\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
234.672\vspace{3pt}}&\multirow{2}{*}{\parbox{\wcF}{\vspace{3pt}\noindent
1.071\vspace{3pt}}}\\\cline{1-5}
\parbox{\wcA}{\vspace{3pt}\noindent
506\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
ING1\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
inhibitor of growth family, member 1; inhibitor of growth 1. [source:refseq;acc:nm\_005537]\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
224.535\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
240.476\vspace{3pt}}&\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
507\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
WDR12\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
wd-repeat protein 12 (ytm1 homolog). [source:swissprot;acc:q9gzl7]\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
251.299\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
234.729\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
1.07059\vspace{3pt}}\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
508\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
CPA3\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
mast cell carboxypeptidase a precursor (ec 3.4.17.1) (mc-cpa) (carboxypeptidase a3). [source:swissprot;acc:p15088]\vspace{3pt}}&\multirow{2}{*}{\parbox{\wcD}{\vspace{3pt}\noindent
177.698\vspace{3pt}}}&\parbox{\wcE}{\vspace{3pt}\noindent
190.24\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
1.07058\vspace{3pt}}\\\cline{1-3}\cline{5-6}
\parbox{\wcA}{\vspace{3pt}\noindent
509\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
CPA6\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
carboxypeptidase b precursor. [source:refseq;acc:nm\_020361]\vspace{3pt}}&&\parbox{\wcE}{\vspace{3pt}\noindent
190.239\vspace{3pt}}&\multirow{2}{*}{\parbox{\wcF}{\vspace{3pt}\noindent
1.07057\vspace{3pt}}}\\\cline{1-5}
\parbox{\wcA}{\vspace{3pt}\noindent
510\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
CPB2\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
plasma carboxypeptidase b2 isoform a preproprotein; carboxypeptidase u; thrombin-activatable fibrinolysis inhibitor; carboxypeptidase b-like protein; thrombin-activable fibrinolysis inhibitor. [source:refseq;acc:nm\_001872]\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
177.699\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
190.24\vspace{3pt}}&\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
511\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
NOL1\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
proliferating-cell nucleolar antigen p120 (proliferation-associated nucleolar protein p120). [source:swissprot;acc:p46087]\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
250.053\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
233.725\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
1.06986\vspace{3pt}}\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
512\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
BOP1\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
block of proliferation 1. [source:swissprot;acc:q14137]\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
250.794\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
234.433\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
1.06979\vspace{3pt}}\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
513\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
DVL1\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
segment polarity protein dishevelled homolog dvl-1 (dishevelled-1) (dsh homolog 1). [source:swissprot;acc:o14640]\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
218.596\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
204.344\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
1.06975\vspace{3pt}}\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
514\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
DVL2\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
segment polarity protein dishevelled homolog dvl-2 (dishevelled-2) (dsh homolog 2). [source:swissprot;acc:o14641]\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
218.613\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
204.382\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
1.06963\vspace{3pt}}\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
515\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
PES1\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
pescadillo homolog 1. [source:swissprot;acc:o00541]\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
251.297\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
234.941\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
1.06962\vspace{3pt}}\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
516\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
LSM8\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
u6 snrna-associated sm-like protein lsm8. [source:swissprot;acc:o95777]\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
228.255\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
213.422\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
1.0695\vspace{3pt}}\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
517\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
MTX2\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
metaxin 2. [source:swissprot;acc:o75431]\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
219.537\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
234.793\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
1.06949\vspace{3pt}}\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
518\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
GNL3\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
nucleostemin; putative nucleotide binding protein, estradiol-induced. [source:refseq;acc:nm\_014366]\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
250.858\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
234.563\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
1.06947\vspace{3pt}}\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
519\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
DVL3\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
segment polarity protein dishevelled homolog dvl-3 (dishevelled-3) (dsh homolog 3). [source:swissprot;acc:q92997]\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
218.702\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
204.582\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
1.06902\vspace{3pt}}\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
520\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
SLC35D2\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
sqv-7-like protein (fragment). [source:sptrembl;acc:o95454]\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
214.754\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
229.565\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
1.06897\vspace{3pt}}\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
521\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
EXOSC4\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
exosome complex exonuclease rrp41 (ec 3.1.13.-) (ribosomal rna processing protein 41) (p12a). [source:swissprot;acc:q9npd3]\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
215.237\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
230.07\vspace{3pt}}&\multirow{5}{*}{\parbox{\wcF}{\vspace{3pt}\noindent
1.06891\vspace{3pt}}}\\\cline{1-5}
\parbox{\wcA}{\vspace{3pt}\noindent
522\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
PLRG1\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
pleiotropic regulator 1 (prl1homolog, arabidopsis); pleiotropic regulator 1 (prl1, arabidopsis homolog). [source:refseq;acc:nm\_002669]\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
222.893\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
208.523\vspace{3pt}}&\\\cline{1-5}
\parbox{\wcA}{\vspace{3pt}\noindent
523\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
EXOSC2\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
exosome complex exonuclease rrp4 (ec 3.1.13.-) (ribosomal rna processing protein 4). [source:swissprot;acc:q13868]\vspace{3pt}}&\multirow{3}{*}{\parbox{\wcD}{\vspace{3pt}\noindent
215.237\vspace{3pt}}}&\multirow{3}{*}{\parbox{\wcE}{\vspace{3pt}\noindent
230.07\vspace{3pt}}}&\\\cline{1-3}
\parbox{\wcA}{\vspace{3pt}\noindent
524\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
EXOSC3\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
exosome complex exonuclease rrp40 (ec 3.1.13.-) (ribosomal rna processing protein 40) (p10) (cgi-102). [source:swissprot;acc:q9nqt5]\vspace{3pt}}&&&\\\cline{1-3}
\parbox{\wcA}{\vspace{3pt}\noindent
525\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
EXOSC5\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
exosome complex exonuclease rrp46 (ec 3.1.13.-) (ribosomal rna processing protein 46) (p12b) (chronic myelogenous leukemia tumor antigen 28). [source:swissprot;acc:q9nqt4]\vspace{3pt}}&&&\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
526\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
RRP1\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
nnp-1 protein (novel nuclear protein 1) (nucleolar protein nop52) (nop52) (d21s2056e). [source:swissprot;acc:p56182]\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
250.538\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
234.401\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
1.06884\vspace{3pt}}\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
527\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
DDX31\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
dead (asp-glu-ala-asp) box polypeptide 31 isoform 1; dead/dexh helicase ddx31. [source:refseq;acc:nm\_022779]\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
248.56\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
232.579\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
1.06871\vspace{3pt}}\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
528\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
YME1L1\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
yme1-like 1 isoform 3; atp-dependent metalloprotease ftsh1 homolog. [source:refseq;acc:nm\_014263]\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
222.146\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
237.393\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
1.06864\vspace{3pt}}\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
529\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
DDX18\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
atp-dependent rna helicase ddx18 (dead-box protein 18) (myc-regulated dead-box protein) (mrdb). [source:swissprot;acc:q9nvp1]\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
251.653\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
235.506\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
1.06856\vspace{3pt}}\\\hline
nd{longtable}

    Legend:
    - Rank is the rank after comparing the two networks
    
 - Gene is the ensembl human gene identifier measured by 1 or more probes on the microarray
    
 - Hugo is the HGNC identifier if it exists
    
 - Value Type describes how the microarray measurement was processed. Ranked indicates that we sorted all measurements and use the rank as red and green value. Measured is the normal measurement. Squared and Rooted are the square and square root respecitcely. This might be valueable to compensate for non linear light distributions.
    
 - Network Comparison Type describes whether we divided the red and green types or whether we sutractcted them
    
 - Interaction Map specifies whether we used only the hig hconfidence protein-protein interactions or also included the low confidence interactions.
    
 - Filtered specifies whether we only included the high confidence microarry measurements or not.
    - http://analysis.yellowcouch.org/